Aviva shares are up 42% in 2025 – can they repeat it in 2026 and boost your ISA?

Aviva shares jumped in 2025 – I’m tracking them in my ISA to see if dividends and growth can keep building my passive income next year.

| More on:
Portrait Of Senior Couple Climbing Hill On Hike Through Countryside In Lake District UK Together

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

After years in the doldrums, the Aviva (LSE: AV.) share price has come alive in 2025, making it one of the best-performing stocks in the FTSE 100. With the Direct Line integration progressing at pace and a continued shift toward a capital-light model, the key question is whether this momentum can carry into 2026.

Diversified business model

One aspect many investors miss is that Aviva is both a life and non-life insurer. That distinction matters when judging performance over time.

Life insurance is long term and investment-heavy, while non-life insurance is short term and underwriting-driven. Blending the two makes headline profits harder to interpret.

That’s why I focus on a single metric that cuts through the noise: group adjusted operating profit (GAOP). It doesn’t appear directly on the balance sheet or income statement.

GAOP strips out swings in bond yields and equity markets that can distort asset values. Instead, it assumes steady long-term returns, allowing investors to see how well Aviva’s core business is actually performing, rather than how favourable markets happened to be in any given year.

Rising profits

The chart below shows GAOP rising sharply over the past few years, and highlights which divisions contribute the largest share to the total.

Chart showing Aviva's profits broken down by Division

Chart generated by author

The key to judging whether GAOP will keep rising is the contractual service margin (CSM).

Under accounting rules, insurers split the value of a policy into two parts:

  1. Expected future cash flows – premiums in, claims and expenses out
  2. The CSM – essentially unearned profit, recognised gradually as the insurer provides coverage

Think of the CSM as a profit reservoir: Aviva can’t book all the profit when a policy is sold. Instead, it releases it steadily over the life of the policy as the service is delivered.

The impact of the CSM on GAOP is clear. In 2023, CSM stood at £1,170m, rising to £1,852m in 2024. This growth shows the company has a larger reservoir of unearned profits to release in the coming years, providing a strong boost to GAOP and underlying earnings.

Risks

One risk for Aviva’s Direct Line purchase is the broader softening in UK insurance premiums.

Recent industry data shows quoted motor and home insurance premiums have continued to trend lower year on year. Average motor premiums are down around 16% compared with early 2025 levels, with declines across other personal lines as competition intensifies.

If falling premiums continue into 2026, Direct Line’s motor and home insurance profits could be squeezed, limiting the contribution Aviva expects from the acquisition. High competition and ongoing claims costs may mean the company has to lower its prices further or struggle to raise them, which could weigh on future earnings.

Bottom line

For me, Aviva remains a core holding in my Stocks and Shares ISA for passive income. The company’s 5.3% dividend yield, supported by GAOP dividend cover of 1.92 times, provides a reliable income stream that compounds tax-free over time.

GAOP growth, a rising CSM, and disciplined capital-light execution all point to sustainable long-term earnings. I’ve recently added to my holding, reflecting my confidence in how the business is performing.

Combined with the diversified mix of life and non-life insurance, I expect the business to continue generating steady dividends, while capital growth in the stock could further boost my ISA over time.

Please note that tax treatment depends on the individual circumstances of each client and may be subject to change in future. The content in this article is provided for information purposes only. It is not intended to be, neither does it constitute, any form of tax advice. Readers are responsible for carrying out their own due diligence and for obtaining professional advice before making any investment decisions.

Andrew Mackie has positions in Aviva Plc. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

2 stocks to buy before they bounce back in 2026?

Buying undervalued stocks is a great way to try and build wealth. But it’s even better when the companies are…

Read more »

Mixed-race female couple enjoying themselves on a walk
Investing Articles

1 of the FTSE 100’s best bargains to consider for 2026!

Royston Wild discusses a top FTSE 100 share he owns in his portfolio -- and explains why he think it's…

Read more »

British Pennies on a Pound Note
Investing Articles

On a P/E ratio of just 3, is this penny stock a deep bargain?

Christopher Ruane previously made a profit buying and later selling this penny stock. Why has he bought it again, with…

Read more »

Young woman working at modern office. Technical price graph and indicator, red and green candlestick chart and stock trading computer screen background.
Investing Articles

I’ve bought this 6.6%-yielding FTSE 250 share, hoping for a 2026 price recovery

This FTSE 250 share has more than halved in the past five years. But it still offers an attractive dividend…

Read more »

Finger clicking a button marked 'Buy' on a keyboard
Investing Articles

A once-in-a-decade chance to buy these UK income shares cheap?

The investing focus in 2026 might just be returning to long-term income shares after a roller-coaster decade for the UK…

Read more »

A GlaxoSmithKline scientist uses a microscope
Investing Articles

Up 9.9%! Here’s why Oxford Nanopore stock topped the FTSE 250 today

This innovative company's stock price marched higher today in the FTSE 250 index. Might this be my first Stocks and…

Read more »

Tesla building with tesla logo and two teslas in front
Investing Articles

Tesla stock’s defied gravity before. Can it do it again?

Could Tesla stock really be worth close to 300 times earnings -- or more? Christopher Ruane explains his thinking about…

Read more »

Businessman with tablet, waiting at the train station platform
Investing Articles

As Greggs’ share price dives, is this a once-in-a-decade opportunity?

The Greggs share price looks incredibly cheap on paper. But does this represent an attractive dip-buying opportunity? Royston Wild investigates.

Read more »